Dermatology
Skin Cancer
More in Skin Cancer
PD-L1 inhibitor indicated for metastatic or locally advanced disease
A 17-year-old mixed martial arts athlete presented to the doctor with complaints of facial lesions that developed 4 days prior. Can you diagnose the patient?
Meta-analysis shows better PFS, OS with RT-first approach, but issue requires more study
Greatest diagnostic accuracy with experienced dermatologists using dermoscopy
PD-1/PD-L1 inhibitors singled out for association
Differences in absolute, relative risk highlight complexities of analyzing rare events
Two-year survival in second line for patients with BRAF/NRAS wild-type tumors
Knowing what to look for can mean the difference between life and death
Health news and commentary gathered by MedPage Today staff
Only a minority of patients adhered to SUNTRAC screening recommendations
More data for discussion of controversial association between steroids, immunotherapy
Early recurrence after anti-PD-1/L1 likely to benefit more from anti-CTLA-4, targeted agents
A 13-year-old Mexican girl was brought to the doctor by her father for a rash that developed on her face over the last 3 days.
Strategy in a selected population could reduce morbidity and costs, researchers argue
